Back
Brainstorm Cell Therapeutics Vs. Aprea Therapeutics Industry Stock Comparison
Sell
7
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.88
Seasonality Move:
2.27%
Sell
4
APRE
Aprea Therapeutics
Last Price:
4.12
Seasonality Move:
-10.67%
Sell
7
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $1.87. The Score for BCLI is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
4
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy, Sell or Hold?
- The current Aprea Therapeutics [APRE] share price is $3.91. The Score for APRE is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- APRE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $1.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
APRE Stock Price Chart
What is Aprea Therapeutics's stock price today?
-
The Aprea Therapeutics share price today is $3.91
The current trend is moderately bullish and APRE is experiencing slight selling pressure.
BCLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 30.53 | Sell |
Chaikin Money Flow: | -6697 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.82 - 2.88) | Sell |
Bollinger Bands (100): | (2.96 - 5.76) | Sell |
APRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 57.66 | Buy |
Chaikin Money Flow: | -6773 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.57 - 4.01) | Buy |
Bollinger Bands (100): | (3.05 - 4.11) | Buy |
BCLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.97 | Sell |
20-day SMA: | 2.11 | Sell |
50-day SMA: | 3.3 | Sell |
200-day SMA: | 5.56 | Sell |
8-day EMA: | 1.99 | Sell |
20-day EMA: | 2.27 | Sell |
50-day EMA: | 3.11 | Sell |
200-day EMA: | 6.38 | Sell |
APRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.06 | Sell |
20-day SMA: | 3.42 | Buy |
50-day SMA: | 3.29 | Buy |
200-day SMA: | 4.74 | Sell |
8-day EMA: | 3.97 | Sell |
20-day EMA: | 3.65 | Buy |
50-day EMA: | 3.47 | Buy |
200-day EMA: | 4.34 | Sell |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Aprea Therapeutics Earnings Growth & APRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.54 per share, and an increase next year of $1.77 per share.
Brainstorm Cell Therapeutics Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aprea Therapeutics Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |